APA aipamena

Clerico, M., Faggiano, F., Palace, J., Rice, G., Tintorè, M., & Durelli, L. (2008). Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.

Chicago Style aipamena

Clerico, M., F. Faggiano, J. Palace, G. Rice, M. Tintorè, and L. Durelli. Recombinant Interferon Beta or Glatiramer Acetate for Delaying Conversion of the First Demyelinating Event to Multiple Sclerosis. 2008.

MLA aipamena

Clerico, M., et al. Recombinant Interferon Beta or Glatiramer Acetate for Delaying Conversion of the First Demyelinating Event to Multiple Sclerosis. 2008.